Contemporary Oncology
eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
4/2025
vol. 29
 
Share:
Send email
Share:
abstract:
Original paper

Clinical outcomes of fractionated stereotactic radiotherapy for uveal melanoma – a Polish single-centre experience

Adam Deja
1
,
Paulina Baluch
2
,
Marta Wróblewska-Zierhoffer
2
,
Emilia Zwolińska
2
,
Maria Radomiak
1
,
Piotr Milecki
1
,
Iwona Rospond-Kubiak
2

  1. The Maria Skłodowska-Curie Greater Poland Cancer Centre, Poznań, Poland
  2. Department of Ophthalmology, Poznań University of Medical Sciences, Poznań, Poland
Contemp Oncol (Pozn) 2025; 29 (4): 367–369
DOI: https://doi.org/10.5114/wo.2025.155789
Online publish date: 2025/11/03
View full text Get citation
 
PlumX metrics:
The aim of the study is to present the results of the first Polish cohort of patients treated with fractionated stereotactic radiotherapy (fSRT) for large and/or juxtapapillary uveal melanoma (UM). Material and methods: The medical records of the patients who underwent the fSRT for UM in Poznań (cooperation between the Department of Ophthalmology, Poznań University of Medical Sciences and Greater Poland Cancer Centre) in 2014–2020 were retrospectively reviewed. The diagnosis was made in each case after detailed clinical examination, ultrasound and/or choroidal biopsy in selected patients. The irradiation protocol was to deliver 50 Gy in 5 fractions. Results: We identified 27 patients, 12 men, 15 women, with a median age of 61.5 years. The median longitudinal basal diameter of treated tumours was 11.7 mm (range 5.2–17.8 mm), median thickness – 7.5 mm (range 1.7–9.7 mm). The median follow-up was 38 months (range 5–101 months). We observed neovascular glaucoma in 9 (34%) patients, which was the reason for globe removal in 3 (11%) of them. There was one local tumour recurrence (3.8%) with extraorbital extension 6 years post-treatment. Local tumour control in our cohort was 96.2%. By the study end, 5 (18.5%) patients died, including 3 (11%) of metastatic disease. The final visual acuity was logMAR 0.3 or better for 3 patients (11%). Conclusions: As reported also by other authors, fSRT could be a useful treatment modality for selected large and/or juxtapapillary melanomas.
keywords:

uveal melanoma, eye, neoplasm, fractionated stereotactic radiotherapy
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.